{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Bombay Oxygen Investments Ltd
Bombay Oxygen Investments Ltd is Rated Sell
Bombay Oxygen Investments Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Bombay Oxygen Investments Ltd is Rated Sell
Bombay Oxygen Investments Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Five Consecutive Losses Push Bombay Oxygen Investments Ltd to a New 52-Week Low
Bombay Oxygen Investments Ltd’s share price declined to a fresh 52-week low of Rs. 18,500.35 on 23 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed both its sector and broader market indices, reflecting a series of financial and technical headwinds.
Bombay Oxygen Investments Ltd is Rated Sell
Bombay Oxygen Investments Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date analysis of the company’s standing.
Bombay Oxygen Investments Ltd Falls to 52-Week Low Amidst Continued Downtrend
Bombay Oxygen Investments Ltd, a Non Banking Financial Company (NBFC), has declined to a fresh 52-week low of Rs.18,761, marking a significant downturn amid a broader market recovery. The stock has underperformed its sector and the broader market, reflecting ongoing pressures on its financial performance and valuation metrics.
Bombay Oxygen Investments Ltd is Rated Sell
Bombay Oxygen Investments Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Bombay Oxygen Investments Ltd is Rated Sell
Bombay Oxygen Investments Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Why is Bombay Oxygen falling/rising?
On 08-Dec, Bombay Oxygen Investments Ltd witnessed a decline in its share price, falling by 1.37% to close at ₹22,488.00. This movement reflects ongoing short-term weakness despite the company’s strong long-term returns relative to the benchmark Sensex.
Why is Bombay Oxygen falling/rising?
As of 11-Nov, Bombay Oxygen Investments Ltd's stock price is Rs 23,277.00, down 1.78%, and has underperformed significantly with a year-to-date decline of 21.23% compared to the Sensex's increase. Despite a rise in delivery volume, the stock continues to trade below key moving averages, indicating a challenging environment.
Is Bombay Oxygen overvalued or undervalued?
As of November 3, 2025, Bombay Oxygen is considered risky and overvalued, with a PE ratio of -42.06 and poor financial metrics compared to peers like Linde India and Petronet LNG, alongside a year-to-date stock performance of -16.78%, significantly underperforming the Sensex's 7.47% gain.
How has been the historical performance of Bombay Oxygen?
Bombay Oxygen's historical performance from 2009 to 2011 shows consistent growth in net sales and profits, with net sales increasing from 32.51 Cr to 41.74 Cr and profit after tax rising from 0.59 Cr to 4.15 Cr. However, cash flow from operating activities declined from 3.74 Cr to -0.42 Cr, indicating cash management challenges despite overall profitability.
Bombay Oxygen Investments Faces Significant Financial Challenges Amid Declining Sales and Returns
Bombay Oxygen Investments, a microcap NBFC, reported net sales of Rs 23.19 crore for the quarter ending September 2025, a notable decline. Despite a profit after tax of Rs 19.01 crore over six months, the company faced substantial losses in profit metrics and underperformed against the Sensex over the past year.
How has been the historical performance of Bombay Oxygen?
Bombay Oxygen's historical performance from 2009 to 2011 showed steady growth in net sales and profits, with net sales increasing from 32.51 Cr to 41.74 Cr and profit after tax rising from 0.59 Cr to 4.15 Cr. However, cash flow from operating activities turned negative in March 2011, indicating potential liquidity issues despite overall profitability.
Are Bombay Oxygen latest results good or bad?
Bombay Oxygen's latest results are concerning, showing a net loss of ₹5.22 crore in Q2 FY26 and a dramatic 56.23% revenue decline for the first half of the fiscal year, indicating significant operational challenges and a challenging outlook for the company.
Bombay Oxygen Investments Q2 FY26: Severe Profitability Crisis Deepens Amid Operational Struggles
Bombay Oxygen Investments Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹372.00 crores, has reported deeply concerning financial results for Q2 FY26 ended September 2025. The company posted a consolidated net loss of ₹5.22 crores, representing a dramatic reversal from profitability and marking a sequential decline of over 240% compared to the previous four-quarter average. The stock, currently trading at ₹24,605.00, has declined 0.75% following the results announcement, reflecting investor anxiety over the deteriorating operational performance and negative financial momentum.
Bombay Oxygen Investments Faces Declining Performance Amid Market Adjustments in NBFC Sector
Bombay Oxygen Investments, a microcap in the NBFC sector, has recently experienced a change in its evaluation, reflecting a shift in market sentiment. The company has faced significant performance challenges, with notable declines in net sales and profits over recent periods, while trading at a premium compared to peers.
How has been the historical performance of Bombay Oxygen?
Bombay Oxygen has shown steady growth in net sales and profits from 2009 to 2011, with net sales increasing from 32.51 Cr to 41.74 Cr and profit after tax rising from 0.59 Cr to 4.15 Cr. However, cash flow from operating activities turned negative in March 2011, indicating potential cash generation challenges despite overall profitability.
Why is Bombay Oxygen falling/rising?
As of 10-Oct, Bombay Oxygen Investments Ltd is facing a decline in stock price, currently at 24,741.35, with a total loss of 2.59% over the last two days and negative returns across various time frames. The stock is underperforming compared to the benchmark Sensex, indicating a challenging environment and reduced investor confidence.
How has been the historical performance of Bombay Oxygen?
Bombay Oxygen's historical performance from 2009 to 2011 shows steady growth in net sales and profits, with net sales increasing from 32.51 crore to 41.74 crore and profit after tax rising from 0.59 crore to 4.15 crore. However, cash flow from operating activities turned negative in 2011, indicating challenges in cash generation despite profitability growth.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
